Fumito Ito
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 41
- CAR-T cell therapy research 21
- Cancer Immunotherapy and Biomarkers 20
- Cancer Diagnosis and Treatment 3
- Immunology 32
- Immunotherapy and Immune Responses 26
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 7
- Co-authors
- Alfred E. Chang (11 shared papers)Clifford S. Cho (2 shared papers)Layton F. Rikkers (2 shared papers)Takaaki Oba (17 shared papers)Sharon M. Weber (1 shared paper)Seagal Teitz‐Tennenbaum (3 shared papers)Qiao Li (3 shared papers)Takayoshi Yamauchi (12 shared papers)
- Journals
- Cancer Research (5 papers)The Journal of Immunology (5 papers)Journal for ImmunoTherapy of Cancer (5 papers)Annals of Surgery (3 papers)Surgical Oncology Clinics of North America (2 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Fumito Ito
68 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Immunology 686
- Oncology 765
- Surgery 438
- Nephrology 68
- Hepatology 52
Countries citing papers authored by Fumito Ito
This map shows the geographic impact of Fumito Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumito Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumito Ito more than expected).
Fields of papers citing papers by Fumito Ito
This network shows the impact of papers produced by Fumito Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumito Ito. The network helps show where Fumito Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Fumito Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 182 | |
| 2 | Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. | 2003 | 143 |
| 3 | 2008 | 139 | |
| 4 | Current Status and Future Directions | 2013 | 138 |
| 5 | 2021 | 110 | |
| 6 | 2020 | 107 | |
| 7 | 2004 | 102 | |
| 8 | 2014 | 88 | |
| 9 | 2007 | 71 | |
| 10 | 2020 | 56 | |
| 11 | Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. | 2003 | 47 |
| 12 | 2015 | 36 | |
| 13 | 2021 | 35 | |
| 14 | 2022 | 32 | |
| 15 | 2016 | 31 | |
| 16 | 2020 | 27 | |
| 17 | 2013 | 27 | |
| 18 | 2005 | 27 | |
| 19 | 1999 | 27 | |
| 20 | 2018 | 25 |
About Fumito Ito
Fumito Ito is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (26 papers), CAR-T cell therapy research (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (7 papers), Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (686 citations), Oncology (765 citations), Surgery (438 citations), Nephrology (68 citations) and Hepatology (52 citations). Fumito Ito has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Alfred E. Chang, Clifford S. Cho, Layton F. Rikkers, Takaaki Oba, Sharon M. Weber, Seagal Teitz‐Tennenbaum, Qiao Li, Takayoshi Yamauchi, Toshifumi Hoki and Mark D. Long. Their work appears in journals such as Cancer Research, The Journal of Immunology, Journal for ImmunoTherapy of Cancer, Annals of Surgery and Surgical Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.